Contract Testing Laboratories

Contract analytical, microbiological, and stability laboratories — running compendial and validated methods, and defending data integrity for their clients.

What this page does not claim

A sector is an organization’s role in the value chain, not a legal category. SPEQ maps the disciplines and standards that role typically operates under; it does not determine which apply to your organization, and a count of decoded standards measures SPEQ’s coverage.

WHAT THIS SECTOR DOES

Contract testing laboratories run analytical, microbiological, stability, and bioanalytical testing for sponsors, manufacturers, and CROs. They release raw materials and finished product, support stability programs, and generate the compendial data on which a batch disposition or a submission depends. The lab’s result is often the last check before product reaches a patient.

REGULATORY LANDSCAPE

GMP testing labs work to 21 CFR 211 subpart I (laboratory controls) and the USP compendia; GLP-regulated studies to 21 CFR Part 58 and OECD GLP; and many labs additionally carry ISO/IEC 17025 accreditation. Method validation and transfer follow ICH Q2 and USP general chapters, and every result lives under 21 CFR Part 11 data-integrity expectations.

THE OVERSIGHT MODEL

The customer qualifies and audits the lab and remains responsible for the decision made on the lab’s data; the lab is responsible for method suitability, competent execution, and the integrity of the result. A quality/technical agreement defines method ownership, OOS handling, and data return — and the lab must be able to reconstruct any reported result from its raw data on demand.

WHAT QUALITY MEANS HERE

01

Method validation & transfer

Demonstrating that a method is suitable and performs the same at the contract lab as at the originator (ICH Q2, USP) before any reportable result is generated.

02

OOS & OOT investigations

Sound out-of-specification and out-of-trend handling — the single most inspected laboratory process, where weak investigations invalidate the result.

03

Data integrity & raw-data traceability

Audit trails, second-person review, and the ability to reconstruct every reported value from instrument raw data (ALCOA+).

04

Compendial & microbiological control

Correct application of USP methods and microbiological limits, including environmental and sterility testing where in scope.

154
Standards decoded
4
GxP disciplines

STANDARDS SPEQ DECODES · 154

Open the full library →
21 CFR Part 211FDAHIGH INSPECTION RISK
Current Good Manufacturing Practice for Finished Pharmaceuticals
21 CFR Part 210FDA
Current Good Manufacturing Practice in Manufacturing, Processing, Packing, or Holding of Drugs — General
21 CFR Part 820FDAHIGH INSPECTION RISK
Quality Management System Regulation (QMSR) — 21 CFR Part 820
FDA Aseptic Processing GuidanceFDAHIGH INSPECTION RISK
Guidance for Industry — Sterile Drug Products Produced by Aseptic Processing
FDA Process Validation Guidance (2011)FDA
Guidance for Industry — Process Validation: General Principles and Practices
EU GMP Annex 1 (2022)EMAHIGH INSPECTION RISK
Manufacture of Sterile Medicinal Products
EU GMP Annex 15EMA
Qualification and Validation
EU GMP Annex 2EMA
Manufacture of Biological Active Substances and Medicinal Products for Human Use
ICH Q5A(R2)ICH
Viral Safety Evaluation of Biotechnology Products Derived from Cell Lines of Human or Animal Origin
ICH Q9(R1)ICH
Quality Risk Management
ICH Q10ICH
Pharmaceutical Quality System
ICH Q8(R2)ICH
Pharmaceutical Development
ICH Q11ICH
Development and Manufacture of Drug Substances (Chemical and Biotechnological/Biological Entities)
ICH Q12ICH
Technical and Regulatory Considerations for Pharmaceutical Product Lifecycle Management
ICH Q7ICH
Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients
USP <1116>USPHIGH INSPECTION RISK
Microbiological Control and Monitoring of Aseptic Processing Environments
USP <1117>USP
Microbiological Best Laboratory Practices
USP <61>/<62>USP
Microbiological Examination of Nonsterile Products
ISO 14644-2ISO
Cleanrooms and Associated Controlled Environments — Monitoring to Provide Evidence of Cleanroom Performance
ISO 9001:2015ISO
Quality Management Systems — Requirements
ISO 13485:2016ISO
Medical Devices — Quality Management Systems — Requirements for Regulatory Purposes
PIC/S PE 009-16PIC/S
Guide to Good Manufacturing Practice for Medicinal Products
ICH E6(R3)ICHHIGH INSPECTION RISK
Good Clinical Practice (GCP)
ICH E8(R1)ICH
General Considerations for Clinical Studies
21 CFR Part 312FDAHIGH INSPECTION RISK
Investigational New Drug Application (IND)
21 CFR Part 50FDAHIGH INSPECTION RISK
Protection of Human Subjects (Informed Consent)
21 CFR Part 56FDA
Institutional Review Boards (IRBs)
Regulation (EU) 536/2014EMAHIGH INSPECTION RISK
Clinical Trials Regulation (CTR)
21 CFR Part 58FDAHIGH INSPECTION RISK
Good Laboratory Practice for Nonclinical Laboratory Studies
OECD GLP PrinciplesOECD
OECD Principles of Good Laboratory Practice
Directive 2004/10/ECEC
Harmonisation of Laws Relating to the Application of GLP
ICH E2AICH
Clinical Safety Data Management: Definitions and Standards for Expedited Reporting
MHLW Ordinance No. 179PMDA
Japan GMP for Drugs and Quasi-drugs
MHLW Ordinance No. 136MHLW
Japan GQP — Quality Management for Marketing Authorisation Holders
ANVISA RDC 658/2022ANVISA
Brazilian Good Manufacturing Practices for Medicines
NOM-059-SSA1-2015COFEPRIS
Mexican Good Manufacturing Practices for Medicines
ANMAT Disposición 4159/2023ANMAT
Argentine GMP Guide for Medicines
Resolución 1160 de 2016INVIMA
Colombian Good Manufacturing Practices for Medicines
DS 021-2018-SADIGEMID
Peruvian GMP Manual for Pharmaceutical Products
Norma Técnica N° 127ISP Chile
Chilean Good Manufacturing Practices
China GMP (2010 Revision)NMPA
Good Manufacturing Practice for Drugs (China)
Revised Schedule M (2023)CDSCO
India GMP — Schedule M, Drugs and Cosmetics Rules
C.R.C., c. 870, Part C, Div. 2Health CanadaHIGH INSPECTION RISK
Food and Drug Regulations — Part C, Division 2: Good Manufacturing Practices
Health Canada GUI-0001Health Canada
Good Manufacturing Practices Guide for Drug Products
TGA Manufacturing PrinciplesTGA
Australian GMP — Manufacturing Principles (PIC/S Guide)
PDA TR No. 22PDA
Process Simulation for Aseptically Filled Products
ICH Q3D(R2)ICH
Guideline for Elemental Impurities
ISO 14971:2019ISO
Medical Devices — Application of Risk Management to Medical Devices
WHO GCLP (2009)WHO
Good Clinical Laboratory Practice (GCLP)
21 CFR Part 117FDAHIGH INSPECTION RISK
Current Good Manufacturing Practice, Hazard Analysis, and Risk-Based Preventive Controls for Human Food
21 CFR Part 111FDAHIGH INSPECTION RISK
Current Good Manufacturing Practice for Dietary Supplements
Codex CXC 1-1969Codex
General Principles of Food Hygiene
ISO 22000:2018ISO
Food safety management systems — Requirements for any organization in the food chain
21 CFR Part 226FDA
Current Good Manufacturing Practice for Type A Medicated Articles
21 CFR Part 225FDA
Current Good Manufacturing Practice for Medicated Feeds
Regulation (EU) 2019/6EC
Veterinary Medicinal Products
ISO 22716:2007ISO
Cosmetics — Good Manufacturing Practices (GMP): Guidelines on Good Manufacturing Practices
21 CFR Part 1271FDA
Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps)
21 CFR Part 606FDA
Current Good Manufacturing Practice for Blood and Blood Components
Regulation (EU) 2017/745ECHIGH INSPECTION RISK
Medical Device Regulation (MDR)
21 CFR Part 121FDA
Mitigation Strategies to Protect Food Against Intentional Adulteration
21 CFR Part 507FDA
Current Good Manufacturing Practice and Preventive Controls for Food for Animals
VICH GL3(R)VICH
Stability Testing of New Veterinary Drug Substances and Medicinal Products
MoCRA (FD&C Act Ch. VI)FDA
Modernization of Cosmetics Regulation Act of 2022
Regulation (EC) No 1223/2009EC
EU Cosmetic Products Regulation
21 CFR Part 700FDA
Cosmetics — General
FD&C Act §503AFDAHIGH INSPECTION RISK
Pharmacy Compounding — Conditions for Exemption
FD&C Act §503BFDAHIGH INSPECTION RISK
Outsourcing Facilities — Registration and cGMP
USP <795>USPHIGH INSPECTION RISK
Pharmaceutical Compounding — Nonsterile Preparations
USP <797>USPHIGH INSPECTION RISK
Pharmaceutical Compounding — Sterile Preparations
USP <800>USPHIGH INSPECTION RISK
Hazardous Drugs — Handling in Healthcare Settings
State Pharmacy Practice ActsState Boards of PharmacyHIGH INSPECTION RISK
State Pharmacy Practice Acts and Compounding Regulations
21 CFR Part 1301DEA
Registration of Manufacturers, Distributors and Dispensers of Controlled Substances
Ph. Eur.EDQMHIGH INSPECTION RISK
European Pharmacopoeia
CEP (EDQM Certification)EDQM
Certificate of Suitability to the Monographs of the European Pharmacopoeia
IPEC-PQG GMP Guide (v5, 2022)IPECHIGH INSPECTION RISK
Joint IPEC-PQG Good Manufacturing Practices Guide for Pharmaceutical Excipients
ISO/IEC 17025:2017ISO
General requirements for the competence of testing and calibration laboratories
ILAC MRAILAC
ILAC Mutual Recognition Arrangement
ICH Q13ICHHIGH INSPECTION RISK
Continuous Manufacturing of Drug Substances and Drug Products
ICH M7(R2)ICHHIGH INSPECTION RISK
Assessment and Control of DNA Reactive (Mutagenic) Impurities in Pharmaceuticals to Limit Potential Carcinogenic Risk
ICH M10ICHHIGH INSPECTION RISK
Bioanalytical Method Validation and Study Sample Analysis
ICH Q14ICH
Analytical Procedure Development
ICH Q2(R2)ICHHIGH INSPECTION RISK
Validation of Analytical Procedures
EU GMP Annex 17EMAHIGH INSPECTION RISK
Real Time Release Testing and Parametric Release
EU GMP Annex 21EMAHIGH INSPECTION RISK
Importation of Medicinal Products
USP <1223>USP
Validation of Alternative Microbiological Methods
USP <665>USP
Plastic Components and Systems Used to Manufacture Pharmaceutical Drug Products
USP <1207>USP
Package Integrity Evaluation — Sterile Products
21 CFR Part 4FDAHIGH INSPECTION RISK
Regulation of Combination Products (cGMP Requirements)
ISO 20916:2019ISO
In vitro diagnostic medical devices — Clinical performance studies using specimens from human subjects
ICH Q1A(R2)ICHHIGH INSPECTION RISK
Stability Testing of New Drug Substances and Products
ICH Q3C(R9)ICHHIGH INSPECTION RISK
Impurities: Guideline for Residual Solvents
ICH Q6AICHHIGH INSPECTION RISK
Specifications: Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products (Chemical Substances)
USP <1220>USP
Analytical Procedure Life Cycle
USP <232>/<233>USPHIGH INSPECTION RISK
Elemental Impurities — Limits and Procedures
WHO TRS 986, Annex 2WHOHIGH INSPECTION RISK
WHO Good Manufacturing Practices for Pharmaceutical Products: Main Principles
ICH Q6BICHHIGH INSPECTION RISK
Specifications: Test Procedures and Acceptance Criteria for Biotechnological/Biological Products
ICH E9(R1)ICHHIGH INSPECTION RISK
Statistical Principles for Clinical Trials, incl. Addendum on Estimands and Sensitivity Analysis
ICH E3ICHHIGH INSPECTION RISK
Structure and Content of Clinical Study Reports
ICH E2C(R2)ICHHIGH INSPECTION RISK
Periodic Benefit-Risk Evaluation Report (PBRER)
EU GMP Annex 16EMAHIGH INSPECTION RISK
Certification by a Qualified Person and Batch Release
Reg. (EU) 2017/1569ECHIGH INSPECTION RISK
Good Manufacturing Practice for Investigational Medicinal Products
ISO 10993-1:2018ISOHIGH INSPECTION RISK
Biological Evaluation of Medical Devices — Part 1: Evaluation and Testing Within a Risk Management Process
ISO 15189:2022ISOHIGH INSPECTION RISK
Medical Laboratories — Requirements for Quality and Competence
AMBV (SR 812.212.1)Swissmedic
Swiss GMP — Medicinal Products Licensing Ordinance
KGMPMFDS
Korean Good Manufacturing Practice
HSA GMP (PIC/S PE 009)HSA
Singapore GMP Standard
TFDA GMP (PIC/S)TFDA
Taiwan GMP Standard
Thai FDA GMDP / GMP ClearanceThai FDA
Thai Drug Facility Licensing and Good Manufacturing and Distribution Practice
CDCR 1984 / PIC/S GMPNPRA
Malaysia GMP Standard
SFDA GMP GuidelineSFDA
Saudi Good Manufacturing Practice Guideline
Act 101 of 1965 (GMP)SAHPRA
South African GMP — Medicines and Related Substances Act
OECD GLP Advisory No. 22OECD
Advisory Document on GLP Data Integrity
Regulation (EU) 2017/746ECHIGH INSPECTION RISK
In Vitro Diagnostic Medical Devices Regulation (IVDR)
21 CFR Part 830FDA
Unique Device Identification
21 CFR Part 806FDAHIGH INSPECTION RISK
Medical Devices; Reports of Corrections and Removals
Reg. (EC) 852/2004EC
Regulation on the Hygiene of Foodstuffs
21 CFR Part 123FDA
Fish and Fishery Products (Seafood HACCP)
21 CFR Part 112FDA
Standards for the Growing, Harvesting, Packing, and Holding of Produce for Human Consumption
21 CFR Part 106FDAHIGH INSPECTION RISK
Infant Formula Requirements: Current Good Manufacturing Practice, Quality Control Procedures, and Quality Factors
USP <2750>USP
Manufacturing Practices for Dietary Supplements
21 CFR Part 558FDA
New Animal Drugs for Use in Animal Feeds
CSAR (Order No. 727)NMPA
China Cosmetic Supervision and Administration Regulation
Reg. (EU) 2024/1938EC
Regulation on Standards of Quality and Safety for Substances of Human Origin (SoHO)
21 CFR Part 610FDAHIGH INSPECTION RISK
General Biological Products Standards
21 CFR Part 630FDAHIGH INSPECTION RISK
Requirements for Blood and Blood Components Intended for Transfusion or for Further Manufacturing Use
JP XVIIIMHLW
Japanese Pharmacopoeia, 18th Edition
BP 2026MHRA
British Pharmacopoeia 2026
Ph. Int. (12th ed.)WHO
The International Pharmacopoeia
ChP 2025NMPA
Chinese Pharmacopoeia, 2025 Edition
APIC "How to do" ICH Q7 (v17)APIC
APIC "How to do" Document: Interpretation of the ICH Q7 Guide
42 CFR Part 493CMSHIGH INSPECTION RISK
Laboratory Requirements (CLIA)
40 CFR Part 160EPA
Good Laboratory Practice Standards (FIFRA)
PIC/S PE 010-4PIC/S
Guide to Good Practices for the Preparation of Medicinal Products in Healthcare Establishments
USP <825>USP
Radiopharmaceuticals — Preparation, Compounding, Dispensing, and Repackaging
ISO 19011:2018ISO
Guidelines for Auditing Management Systems
OECD GLP Advisory No. 17OECD
Application of GLP Principles to Computerised Systems
EMA/INS/GCP/532137/2010EMA
Reflection Paper for Laboratories That Perform the Analysis or Evaluation of Clinical Trial Samples
IP 2026IPC
Indian Pharmacopoeia (IP 2026, 10th Edition)
ISO/IEC 27001:2022ISO
Information Security, Cybersecurity and Privacy Protection — Information Security Management Systems — Requirements
21 CFR Part 3FDA
Product Jurisdiction
21 CFR Part 201FDAHIGH INSPECTION RISK
Labeling
21 CFR Part 202FDA
Prescription Drug Advertising
21 CFR Part 207FDA
Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs That Are Regulated Under a Biologics License Application, and Animal Drugs
21 CFR Part 807FDA
Establishment Registration and Device Listing for Manufacturers and Initial Importers of Devices
ICH M4(R4)ICH
Organisation of the Common Technical Document for the Registration of Pharmaceuticals for Human Use
Directive 2001/83/ECEC
Community Code Relating to Medicinal Products for Human Use
Regulation (EU) 2016/679EC
General Data Protection Regulation (GDPR)
ISO 22301:2019ISO
Security and Resilience — Business Continuity Management Systems — Requirements
ISO 31000:2018ISO
Risk Management — Guidelines
EMA/CHMP/CVMP/SWP/169430/2012EMAHIGH INSPECTION RISK
Guideline on Setting Health Based Exposure Limits for Use in Risk Identification in the Manufacture of Different Medicinal Products in Shared Facilities
ISO 45001:2018ISO
Occupational Health and Safety Management Systems — Requirements with Guidance for Use
ISO 14001:2015ISO
Environmental Management Systems — Requirements with Guidance for Use
WHO LBM 4th ed. (2020)WHO
Laboratory Biosafety Manual, Fourth Edition

WHERE QUALITY FAILS

  • Invalidated or unreliable results from methods that were never properly transferred
  • Out-of-specification results closed without scientifically sound investigation
  • Audit-trail gaps that prevent reconstruction of a reported result
  • Contamination or handling errors in the microbiology or sterility suite

Contract Testing Laboratories: frequently asked questions

Reference answers on what a contract testing laboratories does, what governs it, and who is accountable for quality.

What is a contract testing laboratory?

A contract testing laboratory runs analytical, microbiological, stability, and bioanalytical testing for sponsors, manufacturers, and CROs. It releases raw materials and finished product, supports stability programs, and generates the compendial data on which a batch disposition or a submission depends — often the last check before product reaches a patient.

What regulations govern a testing laboratory?

GMP testing labs work to 21 CFR 211 subpart I (laboratory controls) and the USP compendia; GLP-regulated studies to 21 CFR Part 58 and OECD GLP. Many labs additionally carry ISO/IEC 17025 accreditation. Method validation and transfer follow ICH Q2 and USP general chapters, and every result lives under 21 CFR Part 11 data-integrity expectations.

What does ISO/IEC 17025 accreditation mean for a lab?

ISO/IEC 17025 is the international standard for the competence of testing and calibration laboratories. Accreditation to it is granted per method and per matrix, so the accreditation schedule matters more than the certificate. It signals demonstrated technical competence, but the customer still qualifies and audits the lab and remains responsible for decisions made on its data.